The Global Periodontal Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.62 billion by 2029, growing at a CAGR of 5.91% during the forecast period (2024-2029).
The number of hospital visits related to dental care has decreased since the COVID-19 pandemic outbreak. The main causes of fewer visits to dental clinics were the fear of contracting the virus, postponing dental surgery procedures, and online consultation. Moreover. Following the initial wave of the COVID-19 pandemic, dental practices in some countries appeared to be returning to normal. According to the study titled "The Impact of the COVID-19 Pandemic on Dentistry and Dental Education: A Narrative Review" International Journal of Environmental Research and Public Health in February 2022, after the initial quarantine, about 80% of Italian dentists resumed their regular practice. Due to the virus's long-term evolution, there were some regional variations. For instance, the percentage of dental offices that reopened varied from 36% in the United Kingdom to 47% in Palestine, while it reached 99% in Italy and the United States. Thus, such incidents hampered the market's growth in the initial phase of the outbreak, however, the market is anticipated to gain traction over the coming years.
The growth of the global periodontal market is due to the increasing geriatric population across the world. Medical and dental tourism is experiencing growth in developing markets, which is also one of the prime factors responsible for market growth. For instance, as per a March 2022 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people worldwide, and severe periodontal (gum) disease, which may result in tooth loss, is also common, with almost 10% of the global population affected. Also, as per the United Nation's World Ageing Highlight of 2020, 727 million people were living around the world at the age of 65 and more. This number is expected to reach 1.5 billion by 2050, which complements the growth of the cosmetics dentistry market. As per the report, the share of the geriatric population in the world population was 9.3% in 2020, and by 2050, it is expected to reach 16% of the total world population. Thus, the increasing geriatric population is expected to drive the growth of the market for periodontal treatment as these groups are more prone to dental diseases, thereby driving the demand for the personal market.
Major corporations are creating potential drug candidates to enhance the treatment of periodontal disease which is expected to boost market growth. For instance, in March 2021, Amyndas Pharmaceuticals reported encouraging top-line Phase II results. For its randomised, placebo-controlled clinical trial evaluating AMY-101 in 39 patients with periodontal inflammation and gingivitis.
However, in developing countries, ignorance of personal hygiene is negatively affecting the growth of the periodontal market.
Companies are now focusing on the development of new products to expand their presence in the market. For instance, in October 2020, Summus Medical Laser, one of the global leaders in high-powered laser therapy products, announced the launch of its Horizon Dental Laser System. It is a Class IV therapy laser system designed specifically for dentistry. Furthermore, in December 2020, AMD Lasers introduced its Monet Laser Curing Light, which is a handheld dental device based on diode laser technology designed for dental clinical applications.
Thus, with the benefits associated with lasers treatment and the introduction of new products, the market is expected to flourish in this segment.
Additionally, the market is expanding as a result of the rising number of dental visits. For instance, as per the Early Release of Selected Estimates Based on Data From the 2020 National Health Interview Survey, published in August 2021, reported that 63% of American adults who were 18 years of age or older visited the dentist in 2020. The need for dental care for checkups and treatment is generated by such a high number of dental visits, which is anticipated to propel market expansion. Also, the National Institute of Health article titled 'Estimates of Funding for Various Research, Condition, and Disease Categories' published in June 2021, based on grants, contracts, and other funding methods used by the National Institutes of Health, estimated that annual research support for dental/oral and craniofacial disease of USD 638 million.
The market is expanding as a result of the actions taken by market participants to meet the region's rising demand for dental equipment. For instance, in August 2021, The University of Pennsylvania's ADA Science & Research Institute received a USD2 million grant from the NIH to study the oral mucosa. In the presence of periodontal disease and peri-implantitis, the American Dental Association Science and Research Institute and the University of Pennsylvania School of Dental Medicine will assess the mechanisms that support and impair the barrier function of the oral epithelium. Additionally, in July 2021, Cortexyme in conjunction with its participation at the virtual International Association for Dental Research (IADR) 2021 General Session & Exhibition released new preclinical data showing effective dose range-finding data for its lead drug candidate atuzaginstat (COR388) in periodontal disease.
Thus, all the above mentioned factors expected to boost the segment growth over the forecast period.
This product will be delivered within 2 business days.
The number of hospital visits related to dental care has decreased since the COVID-19 pandemic outbreak. The main causes of fewer visits to dental clinics were the fear of contracting the virus, postponing dental surgery procedures, and online consultation. Moreover. Following the initial wave of the COVID-19 pandemic, dental practices in some countries appeared to be returning to normal. According to the study titled "The Impact of the COVID-19 Pandemic on Dentistry and Dental Education: A Narrative Review" International Journal of Environmental Research and Public Health in February 2022, after the initial quarantine, about 80% of Italian dentists resumed their regular practice. Due to the virus's long-term evolution, there were some regional variations. For instance, the percentage of dental offices that reopened varied from 36% in the United Kingdom to 47% in Palestine, while it reached 99% in Italy and the United States. Thus, such incidents hampered the market's growth in the initial phase of the outbreak, however, the market is anticipated to gain traction over the coming years.
The growth of the global periodontal market is due to the increasing geriatric population across the world. Medical and dental tourism is experiencing growth in developing markets, which is also one of the prime factors responsible for market growth. For instance, as per a March 2022 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people worldwide, and severe periodontal (gum) disease, which may result in tooth loss, is also common, with almost 10% of the global population affected. Also, as per the United Nation's World Ageing Highlight of 2020, 727 million people were living around the world at the age of 65 and more. This number is expected to reach 1.5 billion by 2050, which complements the growth of the cosmetics dentistry market. As per the report, the share of the geriatric population in the world population was 9.3% in 2020, and by 2050, it is expected to reach 16% of the total world population. Thus, the increasing geriatric population is expected to drive the growth of the market for periodontal treatment as these groups are more prone to dental diseases, thereby driving the demand for the personal market.
Major corporations are creating potential drug candidates to enhance the treatment of periodontal disease which is expected to boost market growth. For instance, in March 2021, Amyndas Pharmaceuticals reported encouraging top-line Phase II results. For its randomised, placebo-controlled clinical trial evaluating AMY-101 in 39 patients with periodontal inflammation and gingivitis.
However, in developing countries, ignorance of personal hygiene is negatively affecting the growth of the periodontal market.
Periodontal Market Trends
Laser Treatment Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
In contrast to conventional therapies, laser therapy complements them rather than replaces them. In periodontal laser therapy, your periodontist accesses the inflamed gum tissue from the area surrounding the root of tooth and removes it using a laser. Then they clean away the tartar and plaque that have accumulated below and around the gum line. Dental lasers are devices that produce a narrow beam of light u d to remove or shape a tissue in a dental treatment procedure. Painless and short dental surgeries have been made possible with the help of dental lasers. They are highly effective, depending upon the dentist's ability to control the exposure time and laser power output. According to the World Health Organization's report in May 2020, severe periodontal disease is estimated to affect nearly 10% of the global population. The leading causes of periodontal disease are poor oral hygiene and tobacco use. Thus, rising in periodontal diseases across the globe the demand for dental treatment is expected to increase over the forecast period thereby boosting the segment growth.Companies are now focusing on the development of new products to expand their presence in the market. For instance, in October 2020, Summus Medical Laser, one of the global leaders in high-powered laser therapy products, announced the launch of its Horizon Dental Laser System. It is a Class IV therapy laser system designed specifically for dentistry. Furthermore, in December 2020, AMD Lasers introduced its Monet Laser Curing Light, which is a handheld dental device based on diode laser technology designed for dental clinical applications.
Thus, with the benefits associated with lasers treatment and the introduction of new products, the market is expected to flourish in this segment.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America holds the largest share in the global periodontal market, with the United States being the largest contributor to its revenue. Periodontal disease and tooth decay are the two biggest threats to dental health in the United States.Additionally, the market is expanding as a result of the rising number of dental visits. For instance, as per the Early Release of Selected Estimates Based on Data From the 2020 National Health Interview Survey, published in August 2021, reported that 63% of American adults who were 18 years of age or older visited the dentist in 2020. The need for dental care for checkups and treatment is generated by such a high number of dental visits, which is anticipated to propel market expansion. Also, the National Institute of Health article titled 'Estimates of Funding for Various Research, Condition, and Disease Categories' published in June 2021, based on grants, contracts, and other funding methods used by the National Institutes of Health, estimated that annual research support for dental/oral and craniofacial disease of USD 638 million.
The market is expanding as a result of the actions taken by market participants to meet the region's rising demand for dental equipment. For instance, in August 2021, The University of Pennsylvania's ADA Science & Research Institute received a USD2 million grant from the NIH to study the oral mucosa. In the presence of periodontal disease and peri-implantitis, the American Dental Association Science and Research Institute and the University of Pennsylvania School of Dental Medicine will assess the mechanisms that support and impair the barrier function of the oral epithelium. Additionally, in July 2021, Cortexyme in conjunction with its participation at the virtual International Association for Dental Research (IADR) 2021 General Session & Exhibition released new preclinical data showing effective dose range-finding data for its lead drug candidate atuzaginstat (COR388) in periodontal disease.
Thus, all the above mentioned factors expected to boost the segment growth over the forecast period.
Periodontal Industry Overview
The global periodontal market is highly competitive and consists of several major players. The existing major players in the periodontal market employ strong competitive strategies, leading to a high rivalry among themselves. Moreover, the increasing level of advertising expenses, coupled with powerful strategies, is further increasing the competition among key players. Hence, the presence of major market players, such as Dentsply Sirona, The 3M Company, Medtronic PLC, Straumann AG, and Bausch Health Companies, is increasing the overall competitive rivalry in the market studied. The product advancements and improvement in periodontal products by the major players are increasing the competitive rivalry.Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Methodology
LOADING...
